Long COVID Risk Doubles in Children Following SARS-CoV-2 Reinfection: New Study in The Lancet

A large U.S.-based study published on September 30, 2025, in The Lancet Infectious Diseases reveals that children and adolescents reinfected with SARS-CoV-2—the virus causing COVID-19—face more than double the risk of developing long COVID compared to those infected only once. The study analyzed electronic health records of over 460,000 young patients across 40 pediatric hospitals during the Omicron variant era, from January 2022 to October 2023. This extensive research demonstrates that reinfections notably increase the frequency and severity of post-acute sequelae of SARS-CoV-2 infection (PASC), commonly known as long COVID, highlighting significant public health implications for pediatric populations.

Key Study Findings

The research found that after an initial COVID-19 infection, about 904 children per million developed long COVID within six months. Following reinfection, this incidence increased sharply to approximately 1,884 children per million—more than doubling the risk. The increased risk was consistent across age, gender, ethnicity, vaccination status, severity of the first illness, and underlying conditions like obesity. The study identified serious complications associated with long COVID, including myocarditis (inflammation of the heart muscle), blood clots, kidney injury, cognitive difficulties, fatigue, and respiratory problems. Particularly, the risk of myocarditis tripled after a second infection, and blood clots were over twice as likely.

Dr. Ravi Jhaveri, a co-author and Head of Pediatric Infectious Diseases at Ann & Robert H. Lurie Children’s Hospital and Professor at Northwestern University Feinberg School of Medicine, emphasized the importance of vaccination in mitigating these risks. “These findings add to previous evidence linking pediatric long COVID to multisystem effects and highlight the need to promote vaccination in younger populations,” he said. He stressed that vaccination reduces both initial infections and reinfections, which is crucial for lowering the incidence of long COVID and its severe outcomes in children.

Context and Research Background

This study is part of the National Institutes of Health (NIH)-funded RECOVER Initiative, one of the largest longitudinal efforts aimed at understanding long COVID across ages. Using retrospective cohort methodology, the researchers utilized massive infrastructure and diverse electronic health records (EHR) data to capture post-infection health trends in a pediatric population. The Omicron wave provided a contemporary context of high transmissibility, enabling robust comparisons between first-time infections and reinfections.

Prior to this study, common public perception was that COVID-19 infections in children are typically mild and reinfections pose minimal additional risk. However, this research challenges these assumptions, documenting persistent, sometimes severe, long-term symptoms in children after reinfection. The study also underscores that long COVID is not confined to adults but represents a sustained risk among youth, raising concern for ongoing public health strategies.

Implications for Public Health

The study’s findings carry urgent public health implications. Children with long COVID face prolonged illness that affects multiple organ systems, with potential impacts on their development, schooling, and quality of life. The doubling of long COVID risk after reinfection highlights the importance of preventive measures such as vaccination, masking, and social distancing to reduce transmission in children. Increasing vaccine coverage in pediatric populations can be a key strategy to prevent reinfections and their associated complications.

Experts call for continued research to better identify high-risk subgroups of children prone to severe long COVID symptoms, improve understanding of the biological mechanisms behind pediatric PASC, and develop effective prevention and treatment protocols. The researchers plan to extend surveillance to newer variants and longer follow-up periods to track evolving risk patterns.

Study Limitations and Balanced Perspective

While this study is the largest of its kind, it uses retrospective EHR data with inherent limitations related to data recording and bias. The observational design cannot confirm causation but highlights strong associations between reinfection and increased long COVID risk. Some symptoms of long COVID overlap with other post-viral conditions, making precise diagnosis challenging. Additionally, vaccines, although effective in reducing risk, do not eliminate it entirely. Experts advise interpreting results as part of a broader evidence landscape rather than definitive predictions for every case.

Practical Takeaways for Families

For families and caretakers, this study reinforces the importance of COVID-19 vaccination for children and adolescents to prevent infections and reinfections. Despite perceptions of mild initial illness, the risk of long-lasting complications should encourage proactive vaccination and continued adherence to public health guidelines—especially in settings with high transmission rates. Awareness of long COVID symptoms, prompt medical evaluation, and supportive care for affected children are essential steps to mitigate the impact of this condition.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References